Advertisement
Singapore markets open in 8 hours 41 minutes
  • Straits Times Index

    3,338.57
    +5.77 (+0.17%)
     
  • S&P 500

    5,470.52
    +10.04 (+0.18%)
     
  • Dow

    39,171.09
    +52.23 (+0.13%)
     
  • Nasdaq

    17,843.48
    +110.87 (+0.63%)
     
  • Bitcoin USD

    63,193.82
    +1,648.45 (+2.68%)
     
  • CMC Crypto 200

    1,307.51
    +5.44 (+0.42%)
     
  • FTSE 100

    8,166.76
    +2.64 (+0.03%)
     
  • Gold

    2,338.50
    -1.10 (-0.05%)
     
  • Crude Oil

    82.93
    +1.39 (+1.70%)
     
  • 10-Yr Bond

    4.4810
    +0.1380 (+3.18%)
     
  • Nikkei

    39,631.06
    +47.98 (+0.12%)
     
  • Hang Seng

    17,718.61
    +2.11 (+0.01%)
     
  • FTSE Bursa Malaysia

    1,598.20
    +8.11 (+0.51%)
     
  • Jakarta Composite Index

    7,139.63
    +76.05 (+1.08%)
     
  • PSE Index

    6,398.77
    -13.14 (-0.20%)
     

Earnings Beat: Concentrix Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

It's been a good week for Concentrix Corporation (NASDAQ:CNXC) shareholders, because the company has just released its latest second-quarter results, and the shares gained 4.3% to US$63.28. It looks like a credible result overall - although revenues of US$2.4b were in line with what the analysts predicted, Concentrix surprised by delivering a statutory profit of US$0.98 per share, a notable 16% above expectations. Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there's been a strong change in the company's prospects, or if it's business as usual. With this in mind, we've gathered the latest statutory forecasts to see what the analysts are expecting for next year.

View our latest analysis for Concentrix

earnings-and-revenue-growth
earnings-and-revenue-growth

After the latest results, the five analysts covering Concentrix are now predicting revenues of US$9.63b in 2024. If met, this would reflect a notable 11% improvement in revenue compared to the last 12 months. Per-share earnings are expected to ascend 12% to US$4.47. Before this earnings report, the analysts had been forecasting revenues of US$9.60b and earnings per share (EPS) of US$4.72 in 2024. The analysts seem to have become a little more negative on the business after the latest results, given the small dip in their earnings per share numbers for next year.

ADVERTISEMENT

The consensus price target held steady at US$88.80, with the analysts seemingly voting that their lower forecast earnings are not expected to lead to a lower stock price in the foreseeable future. It could also be instructive to look at the range of analyst estimates, to evaluate how different the outlier opinions are from the mean. Currently, the most bullish analyst values Concentrix at US$125 per share, while the most bearish prices it at US$65.00. This is a fairly broad spread of estimates, suggesting that analysts are forecasting a wide range of possible outcomes for the business.

Looking at the bigger picture now, one of the ways we can make sense of these forecasts is to see how they measure up against both past performance and industry growth estimates. The analysts are definitely expecting Concentrix's growth to accelerate, with the forecast 24% annualised growth to the end of 2024 ranking favourably alongside historical growth of 15% per annum over the past three years. Compare this with other companies in the same industry, which are forecast to grow their revenue 5.6% annually. It seems obvious that, while the growth outlook is brighter than the recent past, the analysts also expect Concentrix to grow faster than the wider industry.

The Bottom Line

The most important thing to take away is that the analysts downgraded their earnings per share estimates, showing that there has been a clear decline in sentiment following these results. Happily, there were no major changes to revenue forecasts, with the business still expected to grow faster than the wider industry. The consensus price target held steady at US$88.80, with the latest estimates not enough to have an impact on their price targets.

With that said, the long-term trajectory of the company's earnings is a lot more important than next year. We have forecasts for Concentrix going out to 2026, and you can see them free on our platform here.

It is also worth noting that we have found 4 warning signs for Concentrix (1 is potentially serious!) that you need to take into consideration.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com